Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of diseases
3.2.1.2 Technological advancements
3.2.1.3 Emphasis on personalized medicine
3.2.1.4 Growth of contract research organizations (CROs)
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 qPCR systems
5.3 Reagents and consumables
5.4 Software
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Gene expression
6.3 Genotyping
6.4 Pathogen detection
6.5 Diagnostics
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Diagnostics laboratories
7.3 Hospitals & clinics
7.4 Pharma & biotech companies
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Agilent Technologies, Inc.
9.3 Azure Biosystems Inc.
9.4 Bio Molecular Systems
9.5 BIOMÉRIEUX SA
9.6 Bio-Rad Laboratories, Inc.
9.7 Danaher Corporation
9.8 Eppendorf
9.9 F. Hoffmann-La Roche Ltd.
9.10 Merck KGaA
9.11 QIAGEN N.V.
9.12 Quantabio
9.13 Siemens Healthineers AG
9.14 Takara Bio Inc.
9.15 Thermo Fisher Scientific Inc.
